CYTOKINETICS (CYTK) EVP exercises options, sells 3,500 shares in open market
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CYTOKINETICS INC EVP Research & Development Fady Ibraham Malik reported an exercise-and-sale transaction in company stock. He sold 3,500 shares of common stock in an open-market sale at $86.62 per share and exercised options to acquire 3,500 shares at $7.80 per share. Following these transactions, he directly holds 153,902 shares of common stock and 37,386 non-qualified stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 3,500 shares ($303,170)
Net Sell
3 txns
Insider
Malik Fady Ibraham
Role
EVP Research & Development
Sold
3,500 shs ($303K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (Right to Buy) | 3,500 | $0.00 | -- |
| Exercise | Common Stock | 3,500 | $7.80 | $27K |
| Sale | Common Stock | 3,500 | $86.62 | $303K |
Holdings After Transaction:
Non-Qualified Stock Option (Right to Buy) — 37,386 shares (Direct, null);
Common Stock — 157,402 shares (Direct, null)
Footnotes (1)
Key Figures
Shares sold: 3,500 shares
Sale price: $86.62 per share
Options exercised: 3,500 shares
+4 more
7 metrics
Shares sold
3,500 shares
Open-market sale of common stock
Sale price
$86.62 per share
Price for 3,500 common shares sold
Options exercised
3,500 shares
Non-qualified stock options converted to common
Exercise price
$7.80 per share
Strike price of options exercised
Common shares held
153,902 shares
Direct ownership after transactions
Options remaining
37,386 options
Non-qualified stock options after exercise
Net shares direction
-3,500 shares
transactionSummary netBuySellShares
Key Terms
open-market sale, Non-Qualified Stock Option (Right to Buy), derivative exercise/conversion, exercise price
4 terms
open-market sale financial
"transaction_action: "open-market sale" for 3,500 common shares"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Non-Qualified Stock Option (Right to Buy) financial
"security_title: "Non-Qualified Stock Option (Right to Buy)""
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion" for option transaction"
exercise price financial
"conversion_or_exercise_price: "7.8000" for non-qualified stock option"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider transaction did CYTK executive Fady Ibraham Malik report?
Fady Ibraham Malik reported a combined exercise-and-sale transaction. He exercised options for 3,500 CYTK common shares at $7.80 each, then sold 3,500 shares in an open-market transaction at $86.62 per share on the same date.
What options did the CYTK executive exercise in this Form 4 filing?
The executive exercised 3,500 non-qualified stock options, each with a $7.80 exercise price. These options were convertible into CYTOKINETICS common stock and were part of a grant originally exercisable beginning in March 2018 with expiration in February 2028.
What are Fady Ibraham Malik’s CYTOKINETICS holdings after the reported trades?
After the reported transactions, Fady Ibraham Malik directly holds 153,902 CYTOKINETICS common shares. He also retains 37,386 non-qualified stock options, providing additional potential future ownership if those remaining options are exercised before their expiration date.